BioSpace News Archive

Eli Lilly and Company (NYSE: LLY) today announced that Anne White has been promoted to senior vice president of Lilly and president of Lilly Oncology effective September 1, 2018.

Privately-held pharmaceutical company Specialised Therapeutics Australia will today mark its 10th anniversary, unveiling new Australian headquarters and a business plan to drive healthcare innovation over the next decade.

Purolite Life Sciences has adopted software from Ideagen as it looks to enhance quality and compliance processes at its new manufacturing, research, development and quality centre of excellence site based in South Wales.

TESARO, Inc. (NASDAQ: TSRO), an oncology-focused biopharmaceutical company, today announced its participation in three upcoming investor conferences.

Innovative treatment for second most common cause of irreversible blindness goes to clinical trials supported by USD$12m investment from two Australian venture capital firms

Quidel Corporation announced today that it has received 510(k) clearance and Clinical Laboratory Improvement Amendments (CLIA) waiver from the United States Food and Drug Administration (FDA) to market its Sofia 2 Lyme FIA

CPhI Worldwide the world’s largest pharma event – taking place in Madrid October (9-11) and organized by UBM (part of Informa plc) – releases the first part of its 6th Annual Report with a stark warning from Girish Malhotra, President of EPCOT International, that regulators are holding back the industry’s ability to innovate.

he U.S. weight loss market is now worth a record $66 billion, but the number of dieters has fallen, due to the growth of the size acceptance and body positivity movement. Do-it-yourself plans still abound as consumers use more diet & fitness apps.

Greiner Bio-One North America Inc. is proud to announce the launch of a new line of Erlenmeyer Shaker Flasks.

Brown & Toland Chief Executive Officer Kelly Robison announced today the addition of three executives to its leadership team: Chief Financial Officer Lynn Grennan, Vice President, Business Development Therese Crossett, and Vice President, Human Capital, Elisa Johnson.